What is the appropriate management for a patient with medial epicondylitis (golfer’s elbow) who is taking apixaban (Eliquis) and has limited elbow extension and flexion?

Management of Medial Epicondylitis in a Patient on Apixaban with Limited Range of Motion

For this patient with medial epicondylitis on Eliquis who cannot fully extend or flex the elbow, initiate conservative management immediately with activity modification, NSAIDs (if no contraindication), and physical therapy focused on eccentric strengthening—do NOT stop the Eliquis for conservative treatment, and avoid corticosteroid injections given the anticoagulation increases bleeding risk.

Initial Conservative Management

The patient's point tenderness at the medial epicondyle with restricted range of motion indicates medial epicondylitis (golfer's elbow), which responds well to conservative therapy in most cases 1. The treatment approach should be:

First-Line Interventions (Weeks 0-6)

• Activity modification: Eliminate repetitive wrist flexion and forearm pronation movements that aggravate symptoms 2
• NSAIDs: Use oral NSAIDs for pain control if no contraindication exists. While the patient is on apixaban, NSAIDs do increase bleeding risk when combined with anticoagulants 3, but this is primarily a concern for chronic NSAID use and major bleeding events—short-term use for symptom control is reasonable with monitoring
• Physical therapy: Begin eccentric strengthening exercises of the flexor-pronator mass once acute pain subsides 1, 2
• Orthotics: Consider counterforce bracing, though evidence for effectiveness is not definitive 1

Critical Caveat Regarding Corticosteroid Injections

Avoid corticosteroid injections in this anticoagulated patient. While corticosteroid injections are more effective than NSAIDs in the acute phase of epicondylosis 1, the combination of apixaban and injection carries increased bleeding risk. The evidence shows that preoperative injections do not significantly impact outcomes if surgery becomes necessary 4, so delaying or avoiding injections does not compromise future treatment options.

Addressing the Anticoagulation

Continue apixaban without interruption for conservative management. The Eliquis FDA label specifies discontinuation only for surgery or invasive procedures 3:

• 48 hours prior for procedures with moderate-to-high bleeding risk
• 24 hours prior for procedures with low bleeding risk
• Bridging is not generally required during this interruption period

Conservative treatment of medial epicondylitis does not require anticoagulation interruption. Physical therapy, bracing, and oral medications pose no significant bleeding risk.

Timeline and Escalation

Most patients respond to conservative management within 6 months 4. The typical progression is:

1. Weeks 0-6: Activity modification, NSAIDs, and initial physical therapy
2. Weeks 6-12: Progressive eccentric strengthening and return to modified activities
3. Months 3-6: Full rehabilitation program with gradual return to normal activities

When to Consider Surgery

Surgical referral is appropriate only after 6 months of failed conservative treatment 4, 5. If surgery becomes necessary:

• Timing: Elective surgery should be scheduled when the patient's thrombotic risk allows for safe anticoagulation interruption
• Perioperative management: Apixaban should be stopped 48 hours before surgery (this is a moderate bleeding risk procedure) 6, 3
• Resumption: Restart apixaban once adequate hemostasis is achieved postoperatively 6, 3
• Surgical outcomes: Success rates range from 63-100% with low complication rates (4.3%) across open, arthroscopic, and percutaneous techniques 5

Monitoring the Limited Range of Motion

The restricted elbow extension and flexion is concerning and requires close monitoring. While this can occur with severe medial epicondylitis, consider:

• Elbow effusion or hemarthrosis: The anticoagulation could theoretically contribute to joint bleeding if there's been trauma, though this is uncommon with apixaban at therapeutic doses
• Concomitant ulnar neuritis: Check for ulnar nerve symptoms (numbness in ring/small fingers, weakness of intrinsic hand muscles). If present, this does not significantly affect surgical outcomes if surgery becomes necessary 4
• Mechanical block: Ensure there's no loose body or other intra-articular pathology limiting motion

If range of motion does not improve with initial conservative measures within 2-3 weeks, obtain imaging (MRI) to evaluate for alternative diagnoses or complications.

Practical Algorithm

Week 0-2:

• Stop aggravating activities
• Start NSAIDs (short course, monitor for bleeding)
• Apply counterforce brace
• Continue apixaban without interruption

Week 2-6:

• Begin physical therapy with eccentric exercises
• Avoid corticosteroid injections due to anticoagulation
• Monitor range of motion improvement

Month 2-6:

• Progressive strengthening program
• Gradual return to activities
• If no improvement by 6 months, refer to orthopedic surgery

If surgery needed:

• Coordinate with prescribing physician regarding apixaban indication and thrombotic risk
• Stop apixaban 48 hours preoperatively 6, 3
• Resume once hemostasis achieved 3